Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to $2.4 million.

  • Protalix BioTherapeutics' Profit After Tax fell 2722.5% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 15615.24%. This contributed to the annual value of $2.9 million for FY2024, which is 6472.57% down from last year.
  • Latest data reveals that Protalix BioTherapeutics reported Profit After Tax of $2.4 million as of Q3 2025, which was down 2722.5% from $164000.0 recorded in Q2 2025.
  • Protalix BioTherapeutics' 5-year Profit After Tax high stood at $19.3 million for Q2 2023, and its period low was -$11.2 million during Q2 2021.
  • Over the past 5 years, Protalix BioTherapeutics' median Profit After Tax value was -$3.6 million (recorded in 2022), while the average stood at -$1.7 million.
  • In the last 5 years, Protalix BioTherapeutics' Profit After Tax crashed by 219654.09% in 2021 and then soared by 46256.09% in 2023.
  • Over the past 5 years, Protalix BioTherapeutics' Profit After Tax (Quarter) stood at -$6.7 million in 2021, then skyrocketed by 43.9% to -$3.7 million in 2022, then plummeted by 61.6% to -$6.0 million in 2023, then soared by 207.45% to $6.5 million in 2024, then crashed by 63.74% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $164000.0 for Q2 2025, and -$3.6 million during Q1 2025.